Just Released! Get realistic market forecasts, state-by-state insights and benchmarks with the new 2024 MJBiz Factbook member program, now with quarterly updates. Make informed decisions.
Health Canada updated its June recall of several cannabis oils and softgels in response to “reported adverse reactions.”
Some of the recalled products were labeled as containing fewer than 3 milligrams of THC per unit, but testing revealed that product samples contained “significant” quantities of the intoxicating cannabinoid hexahydrocannabinol (HHC) as well as THC, the cannabis regulator said in its recall announcement.
“The products contain HHC and THC in quantities that could be intoxicating,” Health Canada’s recall announcement said.
“The presence or quantity of HHC are not indicated on the label.”
The recalled products were sold through authorized retailers in Alberta, British Columbia, Manitoba, Ontario, Saskatchewan and the Yukon, according to Health Canada.
“Additionally, significantly less cannabichromene (CBC) was present than identified on the license holder’s certificate of analysis and/or products labels,” the regulator’s recall announcement said.
“In response, iNaturally Organic Inc. began a voluntary recall of affected and potentially affected products.”
The updated recall added eight new product lots and two new brands, bringing the total number of recalled product lots to 14.
The recalled products include:
- Emprise CBN + CBD 50-milligram softgels (five lots).
- NuLeaf Naturals 1,800-milligram full-spectrum hemp multi-cannabinoid oil (five lots).
- NuLeaf Naturals 1,800-milligram full-spectrum hemp multi-cannabinoid softgels (one lot).
- Naturals full-spectrum hemp multi-cannabinoid oil (one lot).
- Ultra Plus 1,200-milligram multi-cannabinoid oil (one lot).
- Ultra Plus 750-milligram multi-cannabinoid softgels (two lots).
The updated recall marks the regulator’s second product-labeling issue this month.
On Aug. 2, Health Canada recalled Tangerine Dream dried cannabis from Canna Farms because of incorrect cannabinoid values on the product label.
The regulator said 23 units of the product were sold to registered medical marijuana patients between May 31 and July 23.
